One of the out-patient rehab alternatives for individuals in Langhorne battling with opioid abuse and addiction is called opioid maintenance therapy. Some facilities and doctors are authorized to dispense specific meds to opioid dependent individuals, many of which are opioids themselves and are habit forming. In low enough amounts the client doesn't experience being high but also does not experience acute cravings and is not in opioid withdrawal. Methadone is the first drug administered for this reason, but there are a few more choices currently to choose from.
Methadone is an opiate and can be taken at an out-patient clinic licensed to dispense the med, that is taken on a daily basis as a pill or liquid. The cost of the med is approximately $150 per month. Buprenorphine is also an opiate based med, and is in pill form often taken one day on, one day off. But unlike Methadone that can only be administered in well-regulated clinics, Buprenorphine can be prescribed and dispensed in doctor's offices. The cost monthly of buprenorphine is around three hundred dollars per month for the generic of the medication. There is also a version of buprenorphine that contains naloxone, which is a drug that reverses the effects of opioids. An individual consuming this formulation, AKA Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It too is taken every day, and is priced around $450 a month. Naltrexone is an additional med taken in opioid maintenance therapy, but unlike the other medications mentioned it's an opiate blocker and isn't an opioid. There is an option to take this drug as a monthly shot, which is called Vivitrol. As an opioid blocker, it prevents an individual from experience being high from opioids, and in turn lowers the risk associated with relapse. This daily shot costs in the range of $1000 to $1200 monthly.
There are 1 Drug and Alcohol Rehabilitation Programs offering this service in Langhorne, PA
For All Drug and Alcohol Treatment Programs In Langhorne, Click Here.